1-12 of 12
Ying Yan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SOR-CART-MM-001 Study: A Phase I, Open-Label, Dose-Escalation, Pharmacokinetic, and Pharmacodynamic Study of Safety and Efficacy of CAR2 Anti-CD38 A2 CAR-T Cells in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Edward A. Stadtmauer, Omar Elghawy, Todd F. Roberts, Deepu Madduri, Sikander Ailawadhi, Mike Royal, Ying Yan
Journal: Blood
Blood (2023) 142 (Supplement 1): 6851.
https://doi.org/10.1182/blood-2023-178636
Published: 2023
Journal Articles

A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients with Relapsed or Refractory Multiple Myeloma

Rajshekhar Chakraborty, Ying Yan, Mike Royal
Journal: Blood
Blood (2021) 138 (Supplement 1): 4763.
https://doi.org/10.1182/blood-2021-150783
Published: 2021
Journal Articles

Trial in Progress: A Phase 3 Study of Itacitinib or Placebo in Combination with Corticosteroids As Initial Treatment for Chronic Graft-Versus-Host Disease (GRAVITAS-309)

Annie Im, MD, Rodica Morariu-Zamfir, MD, Maureen Bleam, BS, Ying Yan, PhD, Steven Z. Pavletic, MD MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3277.
https://doi.org/10.1182/blood-2019-128586
Published: 2019
Journal Articles

A Biomarker Signature to Predict Complete Response to Itacitinib and Corticosteroids in Acute Graft Versus Host Disease

Michael A. Pratta, MSc, Hao Liu, PhD, Sherry Owens, PhD, Ying Yan, PhD, Michael C. Arbushites, Michael D. Howell, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3279.
https://doi.org/10.1182/blood-2019-124069
Published: 2019
Journal Articles

Preclinical Characterization of an ANTI-CD38/CD3 T CELL-Redirecting Bispecific Antibody

Xiao He, PhD, Yanliang Zhang, PhD, Yun Wei Lai, MSc, Stephanie Baguley, MSc, Yan Li, PhD, Xia Cao, MSc, Ying Yan, PhD, Ken Takeshita, MD, Jerome B. Zeldis, MD PhD, Henry Ji, PhD, Gunnar F. Kaufmann, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4463.
https://doi.org/10.1182/blood-2019-131540
Published: 2019
Journal Articles

A Phase I Trial of Janus Kinase (JAK) Inhibition with INCB039110 in Acute Graft-Versus-Host Disease (aGVHD)

Mark A. Schroeder, MD, H. Jean Khoury, MD FACP, Madan Jagasia, MD MS, Haris Ali, MD, Gary J. Schiller, MD, Michael Arbushites, Patricia Delaite, Ying Yan, Kathleen Rhein, Miguel-Angel Perales, MD, Yi-Bin Chen, MD, John F DiPersio, MD PhD
Journal: Blood
Blood (2016) 128 (22): 390.
https://doi.org/10.1182/blood.V128.22.390.390
Published: 2016
Journal Articles

Activity of Oral Panobinostat (LBH589) in Patients with Myelofibrosis.

Daniel J. DeAngelo, MD, PhD, Andrew Spencer, Thomas Fischer, MD, Thomas Kindler, MD, Oliver G. Ottmann, MD, Miles Prince, MD, Frank J. Giles, MD, MB, FRCPI, FRCPath, Jorge Cortes, MD, Angela Liu, PharmD, Kathryn Parker, PhD, Ying Yan, Jeffrey W. Scott, Kapil N. Bhalla, MD
Journal: Blood
Blood (2009) 114 (22): 2898.
https://doi.org/10.1182/blood.V114.22.2898.2898
Published: 2009
Journal Articles

Detection and Production of Haptoglobin within Acute Myeloid Leukemic Blasts.

Daniel Lingamfelter, DO, Na Yu, Tim Quinn, Casey Williams, Pharm.D., Xiuqin Guan, M.D., Joseph McGuirk, M.D., Yayan Chen, M.D., Stella Abhyyankar, M.D., Navanshu Arora, M.D., Rakesh Gaur, M.D., Jeffery Wiemen, M.D., Ying Yan, M.D.
Journal: Blood
Blood (2007) 110 (11): 4305.
https://doi.org/10.1182/blood.V110.11.4305.4305
Published: 2007
Journal Articles

Serum Proteomic Profiling and Study of Haptoglobin Polymorphisms in Patients with Chronic GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Joseph P. McGuirk, DO, Ying Yan, MD, Hao Gang, PhD, Weijian Hou, PhD, Sunil Abhyankar, MD, Casey Williams, PharmD, Robert Belt, MD, Jianpa Ruan, MD, Weisi Yan, PhD, Jeffery Wieman, MD
Journal: Blood
Blood (2006) 108 (11): 2890.
https://doi.org/10.1182/blood.V108.11.2890.2890
Published: 2006
Journal Articles

Growth Potential of Human Leukemia Blast Cells in SCID Mice and Association with Prognosis of Human Acute Leukemias.

Ying Yan, M.D., Ph. D, Peter Steinherz, M.D., Xiuqin Guan, M.D., Ann Jakubowski, M.D., Joesph P. McGuirk, M.D., Richard J. O’Reilly, M.D.
Journal: Blood
Blood (2004) 104 (11): 1900.
https://doi.org/10.1182/blood.V104.11.1900.1900
Published: 2004
Journal Articles

Generation of Anti-Leukemia Reactive T-Cells by Costimulation with Established B-ALL Cell Lines Expressing Costimulatory Molecules.

Ying Yan, M.D., Ph.D., Peter Steiherz, M.D., Jianda Ruan, M.D., Yibang Chen, Ph.D., Sunil Abhyankar, M.D., Xiuqin Guan, M.D., Casey Williams, PharmD, Robert Belt, M.D., Joseph McGuirk, M.D.
Journal: Blood
Blood (2004) 104 (11): 1094.
https://doi.org/10.1182/blood.V104.11.1094.1094
Published: 2004
Journal Articles

Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages

Yong Jun Liu, Shi Hong Lu, Bin Xu, Ren Chi Yang, Qian Ren, Bin Liu, Bin Li, Min Lu, Feng Ying Yan, Zhi Bo Han, Zhong Chao Han
Journal: Blood
Blood (2004) 103 (12): 4449–4456.
https://doi.org/10.1182/blood-2003-06-1825
Published: 2004